figshare
Browse
12958_2020_610_MOESM2_ESM.pdf (120.55 kB)

Additional file 2 of Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study

Download (120.55 kB)
journal contribution
posted on 2020-05-27, 03:35 authored by Peter Sydow, Norbert Gmeinwieser, Katrin Pribbernow, Christoph Keck, Inka Wiegratz
Additional file 2. Patient disposition.

Funding

Teva GmbH Germany Teva Branded Pharmaceutical Products R&D, Inc., Frazer, PA, USA Theramex HQ UK Ltd

History

Usage metrics

    Reproductive Biology and Endocrinology

    Categories

    Keywords

    OvaleapBiosimilarFollitropin alfaRecombinant human follicle-stimulating hormoneGnRH antagonistUser satisfaction

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC